Excellent achievement for the whole team at Imperial Prostate and the ReIMAGINE consortium

I am humbled to be surrounded by such an enthusiastic and energetic young team. We are all very proud of them. Imperial Urology Imperial Prostate Surgery and Cancer #ipmasterclass22 BAUS

⏱️ #IP7PACIFIC is now recruiting at Imperial NHS 💙! ⏱️ Evaluating the role of biparametric MRI & image-fusion targeted biopsies for the detection of prostate cancer 🔗 imperial.ac.uk/news/233114/re… Hashim U. Ahmed Fran Rawlins Imperial Urology Cancer Research UK Stand Up To Cancer UK #UrSoMe #prostatecancer

I hear at 30 now! Whilst paired cohort studies might show non-inferiority, how will radiologists score, and urologists use, a biparametric MRI when that’s all they have? #IP7PACIFIC is the only pivotal non-inferiority RCT of bpMRI vs. mpMRI

Great milestone! This RCT will answer the key question of mpMRI vs bpMRI for prostate cancer detection Hashim U. Ahmed Anwar Padhani Andrea Rockall Heer Lab

🔬 Tomorrow (20/05) is #InternationalClinicalTrialsDay 🔬 Thank you to our hard working multi-disciplinary research team - and most importantly our patient participants! 🔬 Take a look at #ImperialProstate clinical trials past & present @ imperialprostate.org/clinical-trials

Team Imperial Prostate at #BAUS23! Hashim U. Ahmed Taimur Shah Martin J. Connor Fran Rawlins Nikhil Mayor Alexander Light

🎉 What a fantastic way to end the year at the Surgery and Cancer Awards! Congratulations to everyone at Imperial Prostate for their dedication and hard work in 2023! Imperial Urology Imperial College London Imperial NHS 💙

🧵Imperial NHS 💙 has been awarded £3m by National Institute for Health and Care Research for a new HealthTech Research Centre, led by S&C's George Hanna, to support the development & evaluation of new diagnostic innovations for cancer, infectious & respiratory diseases, critical care, & primary and social care.

Thanks to our enthusiastic chairs Alexander Light and Mr Arnas Rakauskas. Onto our final plenary session of Day 1: Prostate Biopsy, chaired by johann boaz and Fran Rawlins.

Well done everyone. What a team! Very proud of every single one of them. #ipmasterclass24

We are ✨incredibly proud✨ to be leading the #TRANSFORM prostate cancer screening trial in collaboration with our colleagues from UCL Queen Mary University of London The ICR The Royal Marsden NHS Foundation Trust Imperial College London supported by Prostate Cancer UK National Institute for Health and Care Research Movember UK

We're proud to announce that #OurImperial Professor Hashim Ahmed [Hashim U. Ahmed] and Professor Rakesh Heer are two of the six lead researchers on @ProstateCancerUK's £42 million TRANSFORM screening trial. TRANSFORM is the biggest and most ambitious prostate cancer trial in 20

It’s a complete disgrace. There has to be accountability. This is daily. Who is actually listening to this Thames Water 💧 Port of London Authority LBC

[7/7] Prostate Cancer UK are proud to have launched the £42m TRANSFORM trial to find the best way to screen for prostate cancer, so one day all men at risk are invited for regular tests to find aggressive prostate cancer in time for a cure. prostatecanceruk.org/research/for-r…

Congratulations #IP7PACIFIC - 8️⃣6️⃣5️⃣ patients recruited so far! ⏱️ Evaluating the role of biparametric MRI & image-fusion targeted biopsies to detect prostate cancer 🔗 imperial.ac.uk/news/233114/re… #UrSoMe #prostatecancer #prostatecancerdiagnosis #bpMRI

Fine balance of savings lives & harms of screening for prostate cancer “…we have not shown enough risk mitigation yet to justify a national screening programme.” Which is why Prostate Cancer UK & National Institute for Health and Care Research funded £42M TRANSFORM study thetimes.com/uk/healthcare/…

Prostate cancer is now the most commonly diagnosed cancer in England according to an analysis by Prostate Cancer UK. This #WorldCancerDay, we want to shine a light on the TRANSFORM trial which is looking to find the best way to screen for prostate cancer ➡️ imperial.nhs.uk/about-us/news/… 1/2

The trial is led by researchers Imperial NHS 💙 and Imperial College London with UCL, Queen Mary University of London and The ICR. Backed by Prostate Cancer UK, it is the biggest and most ambitious prostate cancer trial in 20 years that aims to transform diagnosis and reduce prostate cancer deaths by up to 40%. 2/2

Meanwhile! Back at in London, Fran Rawlins gave a brilliant presentation showcasing TRANSFORM at the ImperialCTU Unit Meeting 2025 #prostatecancer #prostatescreening Surgery and Cancer Prostate Cancer UK Hashim U. Ahmed